NorthRock Partners LLC Has $1.91 Million Holdings in Danaher Co. (NYSE:DHR)

NorthRock Partners LLC increased its holdings in Danaher Co. (NYSE:DHR - Free Report) by 129.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,323 shares of the conglomerate's stock after acquiring an additional 4,700 shares during the period. NorthRock Partners LLC's holdings in Danaher were worth $1,910,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of DHR. Heck Capital Advisors LLC purchased a new position in Danaher during the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. acquired a new stake in shares of Danaher during the 4th quarter valued at $31,000. Golden State Wealth Management LLC purchased a new position in shares of Danaher during the 4th quarter valued at $31,000. Strategic Financial Concepts LLC acquired a new position in shares of Danaher in the fourth quarter worth $31,000. Finally, Pineridge Advisors LLC raised its holdings in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after acquiring an additional 57 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares of the company's stock, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares of the company's stock, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Raymond James restated a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Robert W. Baird lowered their price target on Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. StockNews.com raised shares of Danaher from a "hold" rating to a "buy" rating in a research report on Monday, May 12th. Stifel Nicolaus raised shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price for the company in a research report on Friday, March 14th. Finally, The Goldman Sachs Group cut their price target on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a report on Wednesday, April 23rd. Four equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $264.40.

Danaher Stock Performance

NYSE:DHR traded up $5.08 during mid-day trading on Friday, hitting $196.03. 3,868,501 shares of the company's stock traded hands, compared to its average volume of 3,454,106. The firm has a market capitalization of $140.29 billion, a price-to-earnings ratio of 37.13, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The firm has a 50 day moving average of $196.87 and a two-hundred day moving average of $217.47. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The company had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. On average, equities analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.65%. Danaher's payout ratio is 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.